Halo Pharma Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Halo Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013377
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Halo Pharma Inc (Halo) is a contract development and manufacturing organization which offers scientific and development expertise services. It offers project management, formulation development and analytical development services. The organization holds specialization in the development of mini and micro tablets, pellets, beads, powders, capsules, stick pack, liquid suspensions, semi-solid ointments, gels and creams, among others. Halo also offers solids, liquids and sterile ointment; and packaging services. The company offers testing services through contract development, during commercial manufacturing; and throughout the product lifecycle to support manufacturing. Its dosage forms comprise sterile, ophthalmic ointments and topical gels, non-sterile, controlled drugs, and others. Halo is headquartered in Whippany, New Jersey, the US.

Halo Pharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Halo Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
Halo Pharma Completes Acquisition Of Mirabel Manufacturing Facility From Teva Canada 9
Private Equity 10
SK Capital Acquires Majority Stake in Halo Pharma 10
Partnerships 11
ExxPharma Therapeutics Enters into Agreement with Halo Pharma 11
Acquisition 12
Halo Pharma Acquires Minority Stake In Altus Formulation 12
Halo Pharma Inc – Key Competitors 13
Halo Pharma Inc – Key Employees 14
Halo Pharma Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Corporate Communications 16
Jun 27, 2017: Halo Pharma Welcomes Itzhak Krinsky, Ph.D. to Its Board of Directors 16
Other Significant Developments 17
May 10, 2017: Halo Pharma Announces the Formation of Its Pediatric Center of Excellence for the Development, Reformulation, and Manufacturing of Drug Products in Pediatric Dosage Forms 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Halo Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Halo Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Halo Pharma Completes Acquisition Of Mirabel Manufacturing Facility From Teva Canada 9
SK Capital Acquires Majority Stake in Halo Pharma 10
ExxPharma Therapeutics Enters into Agreement with Halo Pharma 11
Halo Pharma Acquires Minority Stake In Altus Formulation 12
Halo Pharma Inc, Key Competitors 13
Halo Pharma Inc, Key Employees 14
Halo Pharma Inc, Subsidiaries 15

★海外企業調査レポート[Halo Pharma Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Isetan Mitsukoshi Holdings Ltd.:戦略・SWOT・企業財務分析
    Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • GEN energija, d.o.o.:企業の戦略的SWOT分析
    GEN energija, d.o.o. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Curadev Pharma Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Curadev Pharma Pvt Ltd (Curadev Pharma) is a small molecule drug discovery company that manufactures, discovers, and delivers formulations. The company manufactures formulations and APIs such as cyclodextrin in collaboration with the University of Greenwich and creates and out-licenses pre-I …
  • Titan Logix Corp (TLA):企業の財務・戦略的SWOT分析
    Summary Titan Logix Corp (Titan) is a technology company that offers research and development, manufacturing and marketing of advanced technology fluid management solutions. The company's products include stationary guided wave radar gauges for level measurement and overfill prevention, for use in t …
  • Panacea Biotec Ltd (PANACEABIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Panacea Biotec Ltd (Panacea) is a research-based health management company which focuses on manufactures and commercializes pharmaceuticals; biopharmaceuticals; natural, and indigenous products; and vaccines. Its vaccines portfolio includes paediatric vaccines, including trivalent and monova …
  • Reins International Inc.:企業の戦略・SWOT・財務情報
    Reins International Inc. - Strategy, SWOT and Corporate Finance Report Summary Reins International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pacific Edge Ltd (PEB)-医療機器分野:企業M&A・提携分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It is develo …
  • Dunelm Group plc (DNLM):企業の財務・戦略的SWOT分析
    Dunelm Group plc (DNLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Hospitality Properties Trust:企業のM&A・事業提携・投資動向
    Hospitality Properties Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hospitality Properties Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Grinners Catering (Australia) Pty Ltd:企業の戦略・SWOT・財務分析
    Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • American Axle & Manufacturing Holdings Inc (AXL):企業の財務・戦略的SWOT分析
    American Axle & Manufacturing Holdings Inc (AXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Benchmark Electronics Inc (BHE):企業の財務・戦略的SWOT分析
    Benchmark Electronics Inc (BHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Jamaica Public Service Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Jamaica Public Service Co Ltd (JPS) is an integrated electric utility which generates, procures, transmits, distributes and supplies power. It produces electricity from heavy fuel oil, automotive diesel oil, and hydro sources; and procures energy from independent power producers. The company …
  • Merial Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Merial Ltd (Merial), a subsidiary of Boehringer Ingelheim GmbH, is an animal healthcare center that produces and markets pharmaceutical products and vaccines. The center offers products for dogs, cats, beef, dairy, equine, and swine to improve their health and performance. It develops specif …
  • Hangzhou Tigermed Consulting Co Ltd (300347):企業の財務・戦略的SWOT分析
    Summary Hangzhou Tigermed Consulting Co Ltd (Tigermed) is a contract research organization (CRO) that provides clinical trial services. It offers regulatory submission and approval, medical translation and GMP (Good Manufacturing Practice) consulting, medical monitoring, project management, medical …
  • Occidental Petroleum Corporation (OXY)-石油・ガス分野:企業M&A・提携分析
    Summary Occidental Petroleum Corporation (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream and marketing; and chemicals business. The oil and gas business explores for, develops and produc …
  • Veritas (India) Ltd:企業の戦略・SWOT・財務情報
    Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Casey’s General Stores, Inc.:企業の戦略・SWOT・財務情報
    Casey's General Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Casey's General Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • KARL STORZ SE & Co KG:企業の戦略的SWOT分析
    KARL STORZ SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Enbridge Inc.:企業の戦略・SWOT・財務情報
    Enbridge Inc. - Strategy, SWOT and Corporate Finance Report Summary Enbridge Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆